SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-184215
Filing Date
2015-05-12
Accepted
2015-05-12 17:23:53
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d913798d10q.htm 10-Q 301518
2 EX-31.1 d913798dex311.htm EX-31.1 8061
3 EX-31.2 d913798dex312.htm EX-31.2 8044
4 EX-32.1 d913798dex321.htm EX-32.1 4263
  Complete submission text file 0001193125-15-184215.txt   2749169

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20150331.xml EX-101.INS 272111
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20150331.xsd EX-101.SCH 33813
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20150331_cal.xml EX-101.CAL 44956
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20150331_def.xml EX-101.DEF 91587
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20150331_lab.xml EX-101.LAB 266355
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20150331_pre.xml EX-101.PRE 182936
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 15855553
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences